Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Bujanda

Showing results (331-340 of 423) with videos related to

Pageof 43
Sort By:
Cancers|July 2, 2021
Follow-Up Study Confirms the Presence of Gastric Cancer DNA Methylation Hallmarks in High-Risk Precursor LesionsAntonio Gómez, Miguel L Pato, Luis Bujanda, et al.
Hepatology (Baltimore, Md.)|January 14, 2022
Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipidsMikel Ruiz de Gauna, Francesca Biancaniello, Francisco González-Romero, et al.
Cancers|August 14, 2020
Risk of Cancer in Family Members of Patients with Lynch-Like SyndromeMaría Dolores Picó, Ana Beatriz Sánchez-Heras, Adela Castillejo, et al.
Cells|March 19, 2020
Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease DiagnosisAinhoa Lapitz, Ander Arbelaiz, Colm J O'Rourke, et al.
Hepatology (Baltimore, Md.)|February 11, 2025
Targeting protein hyper-SUMOylation halts cholangiocarcinoma progression by impairing cancer cell viability and tumor-stroma cross talkPaula Olaizola, Irene Olaizola, Marta Fernandez de Ara, et al.
Alimentary Pharmacology & Therapeutics|May 7, 2021
Clinical outcome after anti-tumour necrosis factor therapy discontinuation in 1000 patients with inflammatory bowel disease: the EVODIS long-term studyMaría José Casanova, María Chaparro, Óscar Nantes, et al.
Endoscopy|August 2, 2018
High incidence of advanced colorectal neoplasia during endoscopic surveillance in serrated polyposis syndromeDaniel Rodríguez-Alcalde, Sabela Carballal, Leticia Moreira, et al.
Gastroenterologia Y Hepatologia|December 8, 2019
Prospective, study comparing the accuracy of two different stool antigen tests (Premier Platinum HpSA and novel ImmunoCard STAT! rapid test) for the diagnosis of Helicobacter pylori infectionAdrian G McNicholl, Ana Garre, Laura Llorca, et al.
Gastroenterology|April 8, 2018
Female-Specific Association Between Variants on Chromosome 9 and Self-Reported Diagnosis of Irritable Bowel SyndromeFerdinando Bonfiglio, Tenghao Zheng, Koldo Garcia-Etxebarria, et al.
European Journal of Gastroenterology & Hepatology|April 7, 2020
Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn's diseaseMaría Chaparro, Iván Guerra, Marisa Iborra, et al.
Pageof 43

Showing results (331-340 of 423) with videos related to

Sort By:
Pageof 43
Cancers|July 2, 2021
Follow-Up Study Confirms the Presence of Gastric Cancer DNA Methylation Hallmarks in High-Risk Precursor LesionsAntonio Gómez, Miguel L Pato, Luis Bujanda, et al.
Hepatology (Baltimore, Md.)|January 14, 2022
Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipidsMikel Ruiz de Gauna, Francesca Biancaniello, Francisco González-Romero, et al.
Cancers|August 14, 2020
Risk of Cancer in Family Members of Patients with Lynch-Like SyndromeMaría Dolores Picó, Ana Beatriz Sánchez-Heras, Adela Castillejo, et al.
Cells|March 19, 2020
Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease DiagnosisAinhoa Lapitz, Ander Arbelaiz, Colm J O'Rourke, et al.
Hepatology (Baltimore, Md.)|February 11, 2025
Targeting protein hyper-SUMOylation halts cholangiocarcinoma progression by impairing cancer cell viability and tumor-stroma cross talkPaula Olaizola, Irene Olaizola, Marta Fernandez de Ara, et al.
Alimentary Pharmacology & Therapeutics|May 7, 2021
Clinical outcome after anti-tumour necrosis factor therapy discontinuation in 1000 patients with inflammatory bowel disease: the EVODIS long-term studyMaría José Casanova, María Chaparro, Óscar Nantes, et al.
Endoscopy|August 2, 2018
High incidence of advanced colorectal neoplasia during endoscopic surveillance in serrated polyposis syndromeDaniel Rodríguez-Alcalde, Sabela Carballal, Leticia Moreira, et al.
Gastroenterologia Y Hepatologia|December 8, 2019
Prospective, study comparing the accuracy of two different stool antigen tests (Premier Platinum HpSA and novel ImmunoCard STAT! rapid test) for the diagnosis of Helicobacter pylori infectionAdrian G McNicholl, Ana Garre, Laura Llorca, et al.
Gastroenterology|April 8, 2018
Female-Specific Association Between Variants on Chromosome 9 and Self-Reported Diagnosis of Irritable Bowel SyndromeFerdinando Bonfiglio, Tenghao Zheng, Koldo Garcia-Etxebarria, et al.
European Journal of Gastroenterology & Hepatology|April 7, 2020
Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn's diseaseMaría Chaparro, Iván Guerra, Marisa Iborra, et al.
Pageof 43